Funding for this research was provided by:
DST-NRF Centre Of Excellence In Human Development
South African Medical Research Council (Grants Innovation and Product Development)
Canadian Institutes of Health Research (HLS151553)
Received: 7 February 2022
Accepted: 27 August 2022
First Online: 6 September 2022
: Ethical approval for the HeLTI SA trial and process evaluation was obtained from the Human Research Ethics Committee (Medical) (HREC) of the University of the Witwatersrand, South Africa, with reference numbers M1811111 and M190449. The research is performed in accordance with the Declaration of Helsinki. All participants give informed consent to participate in the trial prior to enrolment.
: Not applicable.
: The authors declare that they have no competing interests.